Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020–2022 in China

Yanfei Wang, Yuke Zhang, Jingjing Quan, Ying Fu, Zhihui Zhou, Jiaqi Xia, Yunsong Yu

Open source

DOI: 10.2147/idr.s624172
Published: 2026-09
Container: Infection and Drug Resistance
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/idr.s624172,
  title = {Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020–2022 in China},
  author = {Yanfei Wang and Yuke Zhang and Jingjing Quan and Ying Fu and Zhihui Zhou and Jiaqi Xia and Yunsong Yu},
  year = {2026},
  journal = {Infection and Drug Resistance},
  doi = {10.2147/idr.s624172},
  url = {https://doi.org/10.2147/idr.s624172}
}

RIS

TY  - JOUR
TI  - Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020–2022 in China
AU  - Yanfei Wang
AU  - Yuke Zhang
AU  - Jingjing Quan
AU  - Ying Fu
AU  - Zhihui Zhou
AU  - Jiaqi Xia
AU  - Yunsong Yu
PY  - 2026
JO  - Infection and Drug Resistance
DO  - 10.2147/idr.s624172
UR  - https://doi.org/10.2147/idr.s624172
ER  -

APA

Wang, Y., Zhang, Y., Quan, J., Fu, Y., Zhou, Z., Xia, J., & Yu, Y. (2026). Ceftolozane/Tazobactam Susceptibility in ESBL-Producing Enterobacterales: Insights from the SMART Program 2020–2022 in China. Infection and Drug Resistance. https://doi.org/10.2147/idr.s624172

Source records

crossref · retrieved 2026-09-27T03:37:51.354Z